JP2007527414A - クロピドグレル組成物の製造方法 - Google Patents

クロピドグレル組成物の製造方法 Download PDF

Info

Publication number
JP2007527414A
JP2007527414A JP2006537245A JP2006537245A JP2007527414A JP 2007527414 A JP2007527414 A JP 2007527414A JP 2006537245 A JP2006537245 A JP 2006537245A JP 2006537245 A JP2006537245 A JP 2006537245A JP 2007527414 A JP2007527414 A JP 2007527414A
Authority
JP
Japan
Prior art keywords
clopidogrel
granules
composition
particles
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006537245A
Other languages
English (en)
Japanese (ja)
Inventor
バラトラジヤン，ラマスワミ
カルカール，パラビ
ロイ，スニル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JP2007527414A publication Critical patent/JP2007527414A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2006537245A 2003-11-03 2004-11-03 クロピドグレル組成物の製造方法 Withdrawn JP2007527414A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0325603.9A GB0325603D0 (en) 2003-11-03 2003-11-03 Organic compounds
PCT/EP2004/012437 WO2005048992A1 (fr) 2003-11-03 2004-11-03 Procede permettant de preparer des compositions de clopidogrel

Publications (1)

Publication Number Publication Date
JP2007527414A true JP2007527414A (ja) 2007-09-27

Family

ID=29725839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006537245A Withdrawn JP2007527414A (ja) 2003-11-03 2004-11-03 クロピドグレル組成物の製造方法

Country Status (8)

Country Link
EP (1) EP1682096A1 (fr)
JP (1) JP2007527414A (fr)
CN (1) CN101848705A (fr)
AU (1) AU2004290511A1 (fr)
BR (1) BRPI0416109A (fr)
CA (1) CA2540965A1 (fr)
GB (1) GB0325603D0 (fr)
WO (1) WO2005048992A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011052500A1 (fr) * 2009-10-28 2011-05-05 第一三共株式会社 Formulation stable à base de cire

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070464A2 (fr) * 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. Formulation de comprimes de bisulfate de clopidogrel
JP2007533746A (ja) 2004-04-20 2007-11-22 サノフイ−アベンテイス クロピドグレル塩及びその多形型
ZA200608569B (en) * 2004-04-20 2007-12-27 Sanofi Aventis Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide
US20060223845A1 (en) * 2005-02-24 2006-10-05 Eran Turgeman Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
DE202005013839U1 (de) * 2005-09-01 2005-10-27 Helm Ag Pharmazeutische Formulierung für Salze monobasischer Säuren mit Clopidogrel
WO2007054968A2 (fr) * 2005-09-20 2007-05-18 Torrent Pahrmaceuticals Limited Compositions pharmaceutiques atypiques de mesylate de clopidogrel
IS2385B (is) * 2006-02-10 2008-07-15 Actavis Group Hf. Klópidógrel bísúlfat lyfjasamsetningar
CZ298349B6 (cs) * 2006-03-09 2007-09-05 Zentiva, A. S Farmaceutická kompozice clopidogrelu hydrogenbromidu
US20100145053A1 (en) * 2006-04-05 2010-06-10 Cadila Healthcare Limited Modified release clopidogrel formulation
ES2342965T5 (es) 2006-04-13 2013-04-03 Acino Pharma Ag Gliceridos parciales como lubricantes para composiciones farmacéuticas que contienen derviados de tieno(3,2-c)piridina
ATE449597T1 (de) * 2006-04-13 2009-12-15 Rentschler Pharma Gmbh Poloxamere als schmiermittel für pharmazeutische zusammensetzungen enthaltend thienoä3,2-cüpyridin-derivate
WO2007128476A1 (fr) * 2006-05-04 2007-11-15 Sandoz Ag Compositions pharmaceutiques contenant du chlorhydrate de clopidogrel
KR20080055355A (ko) * 2006-12-15 2008-06-19 에스케이케미칼주식회사 보관안정성이 우수한 클로피도그렐 함유 포접 복합체
KR20080055356A (ko) * 2006-12-15 2008-06-19 에스케이케미칼주식회사 보관안정성이 우수한 클로피도그렐 함유 포접 복합체
EP1970054A3 (fr) 2007-03-14 2009-06-03 Ranbaxy Laboratories Limited Comprimés de clopidogrel
ES2408380T3 (es) * 2007-04-20 2013-06-20 Wockhardt Limited Composiciones farmacéuticas de clopidogrel
ES2376057T3 (es) * 2008-02-26 2012-03-08 Laboratorios Lesvi, S.L. Formulaciones farmacéuticas que contienen clopidogrel.
EP2107061A1 (fr) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Procédé de préparation de clopidogrel enrichi optiquement
DE602008002820D1 (de) 2008-04-25 2010-11-11 Sandoz Ag Hydrogensulfat von 2-Acetoxy-5-(a-cyclopropylcarbonyl-2-fluorbenzyl)-4,5,6,7-tetrahydrothienoÄ3,2-cÜpyridin und dessen Zubereitung
SI2398468T1 (sl) 2009-02-17 2017-03-31 Krka, D.D., Novo Mesto Farmacevtske sestave, ki obsegajo prasugrel ali njegove farmacevtsko sprejemljive kislinske adicijske soli in postopek za njihovo pripravo
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
CN101766573B (zh) 2010-02-05 2013-02-13 上海安必生制药技术有限公司 硫酸氢氯吡格雷固体制剂的制备工艺
CN101851247B (zh) * 2010-06-04 2013-05-29 浙江华海药业股份有限公司 含有硫酸氢氯吡格雷晶体颗粒的组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2363053C (fr) * 2001-11-09 2011-01-25 Bernard Charles Sherman Formulation pour pastilles de bisulfate de clopidogrel
EP1606231A1 (fr) * 2003-02-03 2005-12-21 Nadkarni, Sunil Sadanand Procede de preparation de clopidogrel, ses sels et compositions pharmaceutiques

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011052500A1 (fr) * 2009-10-28 2011-05-05 第一三共株式会社 Formulation stable à base de cire

Also Published As

Publication number Publication date
EP1682096A1 (fr) 2006-07-26
BRPI0416109A (pt) 2007-01-02
GB0325603D0 (en) 2003-12-10
CA2540965A1 (fr) 2005-06-02
AU2004290511A1 (en) 2005-06-02
WO2005048992A1 (fr) 2005-06-02
CN101848705A (zh) 2010-09-29

Similar Documents

Publication Publication Date Title
JP2007527414A (ja) クロピドグレル組成物の製造方法
JP7216055B2 (ja) 医薬組成物
EP3102186B1 (fr) Compositions de donépézil et procédé de traitement de la maladie d'alzheimer
AU2002237462B2 (en) Oral pharmaceutical composition of cefpodoxime proxetil
JP5600747B2 (ja) 口腔内分散性製剤
EP0349103B1 (fr) Comprimé à mâcher
CA2651138C (fr) Composition pharmaceutique
HU226589B1 (en) Tegaserod pharmaceutical compositions
JP2010514813A (ja) 新規医薬組成物
EP1938804A1 (fr) Préparation pharmaceutique comprenant un antagoniste de neurokinine
EP2934488B1 (fr) Composition pharmaceutique contenant du candésartan cilexetil et de l'amlodipine
CA2599649C (fr) Formulations medicamenteuses ayant une biodisponibilite controlee
JP4880118B2 (ja) 薬物高充填性の即時放出性または放出を修飾した経口用投与処方およびその製法
EP2197424A2 (fr) Composition pharmaceutique améliorée contenant un agent antiviral et procédé de préparation de celle-ci
EP1725217B1 (fr) Procedes pour la preparation de formes posologiques solides de chlorhydrate de valganciclovir amorphe
JP2009538905A (ja) 感湿性薬物を含んで成る安定性製剤及びその製造方法
WO1999020277A1 (fr) Composition medicamenteuse a dissolution rapide
MXPA06004935A (en) Process for preparing clopidogrel compositions
WO2023126973A1 (fr) Composition pharmaceutique stable d'elagolix
JP2004238348A (ja) 経口投与用イトラコナゾール製剤
Alghabban et al. Taste masking of prifinium bromide in orodispersible tablets
CZ296045B6 (cs) Farmaceutická kompozice obsahující jako účinnou látku komplex čtyřmocné platiny a způsob její výroby
JP2007246539A (ja) 速溶性医薬組成物
KR20090016594A (ko) 수분 민감성 약물(들)을 포함하는 안정한 제제 및 이의 제조 절차

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20080108